ENHA Soars 50.9% and CMCT Jumps 46.6% as EPS Revisions Drive Gains
Stocks detected by our EPS revision screener on June 2–7 delivered strong gains, led by ENHA (+50.9%) and CMCT (+46.6%). Marvell Technology (+15.1%) benefited from an S&P 500 inclusion announcement that reinforced its upward EPS revision, while CAVA (+12.3%) was further boosted by a UBS upgrade. All five stocks saw forward EPS growth estimates revised sharply higher, triggering price appreciation as the market confirmed the upgrades.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| ENHA | Consumer Defensive | 2026-06-02 | N/A | +50.9% |
| CMCT | Real Estate | 2026-06-04 | N/A | +46.6% |
| BFLY | Healthcare | 2026-06-07 | N/A | +17.9% |
| MRVL | Technology | 2026-06-01 | N/A | +15.1% |
| CAVA | Consumer Cyclical | 2026-06-07 | N/A | +12.3% |
Why did ENHA stock jump in June 2026?
ENHA surged 50.9% (from $2.83 to $4.27) after analysts raised its forward EPS growth estimate to 140.4% on June 2.
The Consumer Defensive sector saw rotation into small-cap value names, amplifying the revision-driven momentum. With no specific earnings news in the window, the move reflects investors betting on the company's earnings recovery in a defensive sector.
ENHA EPS revision history → · Screener snapshot from 2026-06-02 →
FAQ: ENHA
Why did ENHA stock jump?
ENHA jumped 50.9% after analysts raised its forward EPS growth estimate to 140.4% on June 2, signaling strong earnings recovery expectations.
Is ENHA a buy after the rally?
The rally reflects the EPS revision, but investors should monitor if the company delivers actual earnings growth in line with the 140.4% estimate.
What is ENHA's EPS growth estimate?
ENHA has a forward EPS growth estimate of 140.4% for next year, as of June 2.
Why did CMCT stock jump in June 2026?
CMCT jumped 46.6% (from $3.28 to $4.81) after analysts revised its forward EPS growth estimate to 84.8% on June 4.
The real estate sector rebounded on expectations of lower interest rates, providing tailwinds for CMCT. The upward revision caught the stock at a low point, and the absence of company-specific news suggests macro factors amplified the move.
CMCT EPS revision history → · Screener snapshot from 2026-06-04 →
FAQ: CMCT
Why did CMCT stock jump?
CMCT jumped 46.6% after analysts revised its forward EPS growth estimate to 84.8% on June 4, with real estate sector tailwinds from lower rate expectations.
Is CMCT a buy after the rally?
The EPS revision indicates strong expected growth, but the stock's volatility warrants caution; investors should assess the company's ability to achieve that growth.
What is CMCT's EPS growth estimate?
CMCT's forward EPS growth estimate is 84.8% for next year, as of June 4.
Why did BFLY stock jump in June 2026?
BFLY rose 17.9% (from $4.57 to $5.39) after analysts raised its forward EPS growth estimate to 26.8% on June 7.
The healthcare sector saw increased interest in medical device stocks, and Butterfly Network's innovative ultrasound technology attracted growth investors. The revision provided a fresh catalyst for a stock that had been consolidating.
BFLY EPS revision history → · Screener snapshot from 2026-06-07 →
FAQ: BFLY
Why did BFLY stock jump?
BFLY rose 17.9% after analysts raised its forward EPS growth estimate to 26.8% on June 7, supported by healthcare sector momentum for medical devices.
Is BFLY a buy after the rally?
The EPS revision signals improved earnings prospects, but the stock remains speculative; consider the company's path to profitability.
What is BFLY's EPS growth estimate?
BFLY's forward EPS growth estimate is 26.8% for next year, as of June 7.
Why did MRVL stock jump in June 2026?
MRVL gained 15.1% (from $219.43 to $252.59) after analysts raised its forward EPS growth estimate to 50.9% on June 1.
The upward revision was reinforced by news on June 8 that Marvell will join the S&P 500, triggering mandatory index fund buying, and Nvidia CEO Jensen Huang called Marvell the 'next trillion dollar company.' The custom AI chip business is projected to exceed $10 billion in revenue by fiscal 2029, providing a long-term growth narrative.
MRVL EPS revision history → · Screener snapshot from 2026-06-01 →
FAQ: MRVL
Why did MRVL stock jump?
MRVL jumped 15.1% after analysts raised its forward EPS growth estimate to 50.9% on June 1, with added catalyst from S&P 500 inclusion and Nvidia CEO praise.
Is MRVL a buy after the rally?
The S&P 500 inclusion and strong AI chip prospects support the stock, but the rally has been steep; assess valuation relative to the 50.9% EPS growth estimate.
What caused MRVL's surge?
An upward EPS revision on June 1, followed by the announcement of S&P 500 inclusion on June 8 and bullish commentary from Nvidia's CEO, drove MRVL's surge.
Why did CAVA stock jump in June 2026?
CAVA climbed 12.3% (from $72.60 to $81.56) after analysts raised its forward EPS growth estimate to 35.7% on June 7.
On June 10, UBS upgraded CAVA to Buy with a $90 price target, citing strong same-store sales and industry-leading unit growth, which validated the EPS revision and attracted growth investors. The stock had been pulling back from an April high, and the upgrade provided fresh buying interest.
CAVA EPS revision history → · Screener snapshot from 2026-06-07 →
FAQ: CAVA
Why did CAVA stock jump?
CAVA jumped 12.3% after analysts raised its forward EPS growth estimate to 35.7% on June 7, followed by a UBS upgrade to Buy on June 10.
Is CAVA a buy after the rally?
The UBS upgrade and strong unit growth narrative support a buy thesis, but the stock remains below its 52-week high; monitor same-store sales trends.
What is CAVA's EPS growth estimate?
CAVA's forward EPS growth estimate is 35.7% for next year, as of June 7.
The broad-based rally across consumer defensive, real estate, healthcare, technology, and consumer cyclical stocks suggests investors are rewarding fundamental improvements in earnings outlooks, with small-cap and mid-cap names especially benefiting from revision-driven momentum. The combination of EPS estimate upgrades and reinforcing news catalysts—such as S&P 500 inclusions and analyst upgrades—amplified price moves and attracted growth-oriented capital.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →